Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Decision tool SDR-PEP implementation

ter Ellen F, Tielens K. NLR. 2022;
Publication

Nutritional status of a leprosy patient in a referral hospital: case report / Estado nutricional de um paciente com hanseníase em um hospital de referência: relato de caso

Farias MN, Calças NC, Da Costa LP, et al. South Florida Publishing LLC. Brazilian Journal of Health Review. 2022; 5 (1) : 2192-2202.
Download PDF
Publication

Carga Global de Doenças: Estimativa e tendência temporal da carga da hanseníase no estado de Alagoas, Brasil entre 2001 a 2019

Cabral JSD, Matos DF, Bezerra L, et al. Research, Society and Development. Research, Society and Development. 2022; 11 (2) : e44511225528.
Download PDF
Publication

Cuidado farmacêutico ambulatorial na Hanseníase / Ambulatory pharmaceutical care in Leprosy

Ramos MF, Galete J, Polisel CG. South Florida Publishing LLC. Brazilian Journal of Development. 2022; 8 (1) : 7213-7228.
Download PDF
Publication

Spatio-temporal analysis of leprosy risks in a municipality in the state of Mato Grosso-Brazilian Amazon: results from the leprosy post-exposure prophylaxis program in Brazil.

Machado LMG, dos Santos ES, Cavaliero A, et al. Infectious diseases of poverty. 2022; 11 (1) : 21.
Download PDF
Publication

Chronic type 2 reaction possibly triggered by an asymptomatic Bartonella henselae infection in a leprosy patient.

Santos L, Drummond M, França A, et al. Revista do Instituto de Medicina Tropical de Sao Paulo. 2022;
Download PDF
Publication

Deep Vein Thrombosis in Lepromatous Leprosy: A Case Report of Secondary Pediatric Antiphospholipid Syndrome.

Jones D, CA J, Joshi A, et al. Cureus. 2022; 14 (1) : e21361.
Download PDF
Publication

Symmetrical Centrofacial Erythematous Plaques and Papules: A Clinicopathological Challenge.

Sahni K, Yadav D, Ahuja R, et al. Indian dermatology online journal. 2022; 13 (1) : 102-104.
Download PDF
Publication

The 21 International Leprosy Congress (ILC) -2022.

Indian dermatology online journal. 2022; 13 (1) : 172.
Download PDF
Publication

Mycobacterium leprae Infection in a Wild Nine-Banded Armadillo, Nuevo León, Mexico.

Vera-Cabrera L, Ramos-Cavazos C, Youssef N, et al. Emerging infectious diseases. 2022; 28 (3) : 747-749.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 223
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

  • infontd

© 2025 InfoNTD